Article info
PDFMigraine
Research paper
Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention
- Correspondence to Dr Mario Fernando Prieto Peres, Albert Einstein Hospital, R Joaquim Eugenio de Lima, 881 cj 709, São Paulo 01403-001, Brazil; mariop3r3s{at}gmail.com
Citation
Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention
Publication history
- Received March 2, 2016
- Revised April 5, 2016
- Accepted April 21, 2016
- First published May 10, 2016.
Online issue publication
November 07, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/